Wall Street Is Making House Calls
Big Pharma and private equity are taking over the booming in-home care industry while pushing back against needed reforms.
Health Care
Deep dives into the political corruption and corporate bureaucracy that keeps Americans sick while making executives rich.
YOU LOVE TO SEE IT: The Consumer Watchdog Catches A Break
Plus, sick leave is sticking around, Medicaid tackles climate change, criminal justice reform is helping communities, and another state aims to make Big Oil pay.
YOU LOVE TO SEE IT: Your Constitutional Right To Affordable Meds
Plus, Hawaii prioritizes housing for residents, a tech company cuts off the police, and Vermont votes to make Big Oil pay.
Universities Are Making Billions Gatekeeping Your Meds
The University of California has raked in a previously undisclosed $1.6 billion from Xtandi sales, and now doesn’t want the government lowering exorbitant drug costs.
Pfizer’s Massive Tax Dodge
The pharma giant previously received billions in federal funding and raked in huge profits, but owes nothing in 2023 income taxes thanks to legal loopholes and Trump-era tax cuts.
Where Nursing Homes Hide Their Profits
While industry leaders plead poverty to fight a proposed staffing standard, private equity owners are funneling cash into their affiliated real estate and management firms.
The New War Over Generic Drugs
Why are generic drugmakers fighting a plan to let them make more medicines?
SIROTA’S SIGNALS: Cheeseburgers vs. Water
Plus, a single graph explains Boeing’s crisis, Apple tries to censor its regulator, and Wall Street data debunks the GOP’s anti-ESG crusade.
This New Lawsuit Could Rescind Your Health Care Benefits
Right-wing federal appeal judges signal they support repeal of the no-cost preventive care mandate, all but guaranteeing a Supreme Court showdown.
Pharma’s Dems Are Doing Trump’s Dirty Work On Drug Prices
As the first-ever Medicare drug-price negotiations take shape, Big Pharma-backed Democrats want to limit the number of costly medicines regulators can target.